Literature DB >> 24140062

SIRT5 desuccinylates and activates SOD1 to eliminate ROS.

Zhi-Feng Lin1, Hong-Bing Xu, Jian-Yun Wang, Qiang Lin, Zhen Ruan, Fa-Bing Liu, Wang Jin, Hai-Hua Huang, Xi Chen.   

Abstract

Cu/Zn superoxide dismutase (SOD1) is a key antioxidant enzyme. Deficiency of SOD1 is associated with various human diseases, including cancer. Here, we report that SOD1 is succinylated and that succinylation decreases its activity. SIRT5 binds to, desuccinylates and activates SOD1. SOD1-mediated ROS reduction is increased when SIRT5 is co-expressed. Furthermore, mutation of the SOD1 succinylation site inhibits the growth of lung tumor cells. These results reveal a novel post-translational regulation of SOD1 by means of succinylation and SIRT5-dependent desuccinylation, which is important for the growth of lung tumor cells.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Antioxidation; Cell growth; ROS; SIRT5; Succinylation

Mesh:

Substances:

Year:  2013        PMID: 24140062     DOI: 10.1016/j.bbrc.2013.10.033

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  62 in total

1.  Metabolomics-assisted proteomics identifies succinylation and SIRT5 as important regulators of cardiac function.

Authors:  Sushabhan Sadhukhan; Xiaojing Liu; Dongryeol Ryu; Ornella D Nelson; John A Stupinski; Zhi Li; Wei Chen; Sheng Zhang; Robert S Weiss; Jason W Locasale; Johan Auwerx; Hening Lin
Journal:  Proc Natl Acad Sci U S A       Date:  2016-04-05       Impact factor: 11.205

2.  Acylation of Superoxide Dismutase 1 (SOD1) at K122 Governs SOD1-Mediated Inhibition of Mitochondrial Respiration.

Authors:  Courtney J Banks; Nathan W Rodriguez; Kyle R Gashler; Rushika R Pandya; Jeffrey B Mortenson; Matthew D Whited; Erik J Soderblom; J Will Thompson; M Arthur Moseley; Amit R Reddi; Jeffery S Tessem; Matthew P Torres; Benjamin T Bikman; Joshua L Andersen
Journal:  Mol Cell Biol       Date:  2017-09-26       Impact factor: 4.272

3.  Emerging Roles for SIRT5 in Metabolism and Cancer.

Authors:  Lauren R Bringman-Rodenbarger; Angela H Guo; Costas A Lyssiotis; David B Lombard
Journal:  Antioxid Redox Signal       Date:  2017-10-26       Impact factor: 8.401

Review 4.  Sirtuins and the Metabolic Hurdles in Cancer.

Authors:  Natalie J German; Marcia C Haigis
Journal:  Curr Biol       Date:  2015-06-29       Impact factor: 10.834

5.  Generation and Purification of Catalytically Active Recombinant Sirtuin5 (SIRT5) Protein.

Authors:  Surinder Kumar; David B Lombard
Journal:  Methods Mol Biol       Date:  2016

Review 6.  Function and origin of mistranslation in distinct cellular contexts.

Authors:  Michael H Schwartz; Tao Pan
Journal:  Crit Rev Biochem Mol Biol       Date:  2017-01-11       Impact factor: 8.250

Review 7.  Using mitochondrial sirtuins as drug targets: disease implications and available compounds.

Authors:  Melanie Gertz; Clemens Steegborn
Journal:  Cell Mol Life Sci       Date:  2016-03-23       Impact factor: 9.261

Review 8.  Mitochondrial sirtuins in the heart.

Authors:  Heiko Bugger; Constantin N Witt; Christoph Bode
Journal:  Heart Fail Rev       Date:  2016-09       Impact factor: 4.214

9.  Sirtuin 5 is Anti-apoptotic and Anti-oxidative in Cultured SH-EP Neuroblastoma Cells.

Authors:  Fengyi Liang; Xie Wang; Suet Hui Ow; Wangxue Chen; Wei Chen Ong
Journal:  Neurotox Res       Date:  2016-08-30       Impact factor: 3.911

Review 10.  Mitochondrial Sirtuins in Cancer: Emerging Roles and Therapeutic Potential.

Authors:  Jasmine George; Nihal Ahmad
Journal:  Cancer Res       Date:  2016-04-20       Impact factor: 12.701

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.